SIMON H. STERTZER - 03 Mar 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Purchase	$52,332	+22,753	+127%	$2.30	40,602	03 Mar 2025	Direct	F1
transaction	BCDA	Common Stock	Purchase	$35,733	+15,536	+38%	$2.30	56,138	04 Mar 2025	Direct	F2
holding	BCDA	Common Stock						59,204	03 Mar 2025	See Footnote	F3
holding	BCDA	Common Stock						15,379	03 Mar 2025	See Footnote	F4
holding	BCDA	Common Stock						777	03 Mar 2025	See Footnote	F5
holding	BCDA	Common Stock						6,102	03 Mar 2025	See Footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This transaction was executed in multiple trades ranging from $2.13 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
F2	This transaction was executed in multiple trades ranging from $2.34 to $2.50 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
F3	These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.
F4	These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are the sole members and managers.
F5	These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.
F6	These shares are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such shares.